Trial intelligence / Profile preview

SPM 962 (Rotigotine) in Japanese RLS Patients

NCT00666965Phase 2Completed

Sponsor
Otsuka Pharmaceutical Co., Ltd.
Start
Jun 2008
Primary completion
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of rotigotine in restless legs syndrome (RLS), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Jun 2008; status: completed.

02

Drugs

rotigotine
03

Conditions

restless legs syndrome (RLS)

Beyond the preview

Go deeper on NCT00666965.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00666965.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call